Pfizer has confirmed it is in discussion with labour unions in Korea as part of an evaluation of its business in the country.
Amgen has retracted a study showing how grizzly bears could hold the key to understanding diabetes after one of the authors was found to have manipulated data.
The National Institute of Pharmaceutical Education and Research (NIPER ) in India has created and licensed technology for producing nano-crystal based medicines that it says will cut drug costs.
Novo Nordisk says nuclear submarine veterans’ “mission critical” mentality is suited to pharmaceutical manufacturing environment.
AMRI has inked a deal with Slovakia’s Saneca Pharmaceuticals to bolster its opium-derived API portfolio.